- ホーム
- > 洋書
- > 英文書
- > History / World
Full Description
This collection takes the perspective that the historiography of science, technology, and medicine needs a broader approach toward regulation. The authors explore the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and means of intervention chosen to tame drugs in factories, consulting rooms and courts.
Contents
List of Illustrations List of Tables Notes on Contributors General Introduction; J.P.Gaudillière & V.Hess Secrets, Bureaucracy and the Public: Drug Regulation in Prussia in the 19th century; V.Hess Making Salvarsan. Experimental therapy and the development and marketing of Salvarsan at the interface between science, clinic, industry and public health; A.Hüntelmann Professional and Industrial Regulation in France and Germany: the Trajectories of Plant Extracts; J.P.Gaudillière Making Risks Visible: The Science, Politics and Regulation of Adverse Drug Reactions; H.Marks Regulating Drugs, Regulating Diseases: Consumerism and the U.S. Tolbutamide Controversy; J.Greene Thalidomide, Drug Safety Regulation and the British Pharmaceutical Industry: the Case of Imperial Chemical Industries; V.Quirke What's in a pill? On the Informational Enrichment of Anti-cancer Drugs; A.Cambrosio , P.Keating & A.Mogoutov Treating Health Risks or Putting Healthy Women at Risk: Controversies around Chemoprevention of Breast Cancer; I.Löwy AZT and Drug Regulatory Reform in the Late Twentieth Century US; D.Messner Professional, Industrial and Court Regulation of Drugs: The 1953 Stalinon Case and Pharmaceutical Reform in Postwar France; C.Bonah Managing Double Binds in the Pharmaceutical Prescription Market: The Case of Halcion; T.Pieters & S.Snelders Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens and Generics Laboratories in Brazil and India; M.Cassier
